Naloxone Drug Combination Buprenorphine FDA Link

A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESICS with naloxone, a NARCOTIC ANTAGONISTS to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIOID SUBSTITUTION THERAPY.

Also Known As:

Buprenorphine, Naloxone Drug Combination; Buprenorphine Naloxone; Buprenorphine Naloxone Drug Combination; Buprenorphine-Naloxone; Buprenorphine-Naloxone Combination; Buprenorphine-Naloxone Drug Combination; Suboxone; Buprenorphine Naloxone Combination; Combination, Buprenorphine-Naloxone; Combination, Buprenorphine-Naloxone Drug; Drug Combination, Buprenorphine-Naloxone; Naloxone, Buprenorphine

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Opiate Alkaloids: 5944
    - Morphinans: 33
      - Naloxone: 5958
        Naloxone Drug Combination Buprenorphine: 539
      - Buprenorphine: 4211
        Naloxone Drug Combination Buprenorphine: 539
- Bridged-Ring Heterocyclic Compounds
  - Morphinans: 33
    - Naloxone: 5958
      - Naloxone Drug Combination Buprenorphine: 539
    - Buprenorphine: 4211
      - Naloxone Drug Combination Buprenorphine: 539
- Fused-Ring Heterocyclic Compounds
  - 4 or More Rings Heterocyclic Compounds
    - Morphinans: 33
      - Naloxone: 5958
        Naloxone Drug Combination Buprenorphine: 539
      - Buprenorphine: 4211
        Naloxone Drug Combination Buprenorphine: 539
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Phenanthrenes: 27
    - Morphinans: 33
      - Naloxone: 5958
        Naloxone Drug Combination Buprenorphine: 539
      - Buprenorphine: 4211
        Naloxone Drug Combination Buprenorphine: 539
Pharmaceutical Preparations
- Drug Combinations: 5337
  - Naloxone Drug Combination Buprenorphine: 539

Carmen Albizu Garcia Selected Research

Carmen Albizu Garcia Research Topics

Disease

Drug/Important Bio-Agent (IBA)